Momenta files for IPO

Momenta (Cambridge, Mass.), which engineers complex sugars and glycosylated biomolecules, filed to raise up to $86.3 million in an IPO underwritten by SG Cowen; Banc of America Securities; CIBC World Markets; and ThinkEquity. Within 12 months, Momenta hopes to submit an ANDA for its M-Enoxaparin low-molecular weight heparin, a generic version of Lovenox enoxaparin from Aventis (AVE). ...